2-Hydroxy-5-((4-(N-(Pyridin-2-Yl)Sulfamoyl)Phenyl)Diazenyl)Benzoic Acid 2-羟基-5-((4-(N-(吡啶-2-基)氨磺酰基)苯基)偶氮基)苯甲酸

CAS 599-79-1 MFCD00057363

化学结构图

599-79-1
SMILES: O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O

化学属性

Mol. FormulaC18H14N4O5S
Mol. Weight398
Melting Point246
SolubilitySoluble in DMSO (100 mg/ml), dichloromethane, ethanol (1:2900), methanol (1:1500), aqueous sodium bicarbonate, sodium hydroxide solutions, and 1 M NH4OH (50 mg/ml). Insoluble in water.
Appearance 其外观为棕黄色微细结晶,无臭。微溶于乙醇,不溶于水、氯仿、乙醚、苯。
Stability对光敏感

别名和识别编码

Chemical Name2-Hydroxy-5-((4-(N-(Pyridin-2-Yl)Sulfamoyl)Phenyl)Diazenyl)Benzoic Acid
CAS Number599-79-1
Synonym ######## 2-Hydroxy-5-{{4-[(2-pyridinylamino)sulfonyl]phenyl}azo}benzoic acid 5-[对-(2-吡啶胺磺酰基)苯]偶氮水杨酸 Salicylazosulfapyridine 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene 5-((p-(2-pyridylsulfamoyl)phenyl)azo)-salicyli 5-(4-(2-pyridylsulfamoyl)phenylazo)-2-hydroxybenzoicacid 5-[4-(2-P 5-[4-(2-PYRIDYLSULFAMOYL)PHENYLAZO]SALICYLIC ACID 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid 5-[对-(2-吡啶胺磺酰基)苯]偶氮水杨酸 Asulfidine Azopyrin Azulfadine Azulfidine Azulfidine EN Benzosulfa Colo Pleon Colo-Pleon LABOTEST-BB LT00772281 Pleon Pyralin EN SULFASALAZINE Salazopyrin Salazosulfapyridine Salicylazosulfapyridine Sulfasalazin Heyl Sulfasalazin medac Sulfasalazin-Heyl
MDL NumberMFCD00057363
Beilstein Registry Number356241
EC Number209-974-3
Reaxys-RN356241
PubChem Substance ID5339
Merck Number8942
Chemical Name Translation2-羟基-5-((4-(N-(吡啶-2-基)氨磺酰基)苯基)偶氮基)苯甲酸
Wiswesser Line NotationT6NJ BSWMR DNUNR DQ CVQ
InChIInChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Analytical Standards, Chromatography, EP Standards, EP Standards S - T, Pharmaceutical Standards, Pharmacopeia Standards, 分析/色谱
  • {SNA} Alphabetic, Analytical Standards, Analytical/Chromatography, Antibacterial, Antibiotics, Antibiotics A to Z, Antibiotics N-S, Ch
  • {SNA} Analytical Standards,
  • Sulfur & Selenium Compounds
  • Heterocycles
  • {SNA} Analytical Standards, EP Standards, EP Standards S - T, Pharmacopeia & Metrological Institutes Standards, 分析/色谱
  • {SNA} Analytical Standards, Antibacterial, Antibiotics A to Z, Antibiotics N-S, Antibiotics Standards,
  • Pharmaceuticals
  • {SNA} Analytical Standards, Anti

产品应用

  • An inhibitor of of GSH-H-transferase and NF-kB activation and an apoptosis inducer

相关文献及参考

  • Schroder, H., et al.: Clin. Pharmacol. Ther.,13, 539 (1972),
  • McDonnell, J.P., et al.: Anal. Profiles Drug Subs., 5, 515 (1976),
  • Klotz, U., et al.: Clin. Pharmacokinet.,10, 285 (1985),

安全信息

GHS Symbol
WGK Germany2
Precautionary statements
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
  • P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P272 Contaminated work clothing should not be allowed out of the workplace. 污染的工作服不得带出工作场所。
  • P273 Avoid release to the environment. 避免释放到环境中。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P281 Use personal protective equipment as required. 使用所需的个人防护装备。
  • P285 In case of inadequate ventilation wear respiratory protection. 在通风不足的情况下,戴呼吸防护。
  • P301+P312
  • P302+P352
  • P304+P341
  • P308+P313
  • P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
  • P330 Rinse mouth. 漱口
  • P333+P313
  • P342+P311
  • P363 Wash contaminated clothing before reuse. 被污染的衣服洗净后方可重新使用。
  • P391 Collect spillage. Hazardous to the aquatic environment 收集对水环境有危害的泄漏物。
  • P405 Store locked up. 上锁保管。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Hazard statements
  • H317 May cause an allergic skin reaction 可能导致皮肤过敏
  • H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled 吸入可能导致过敏或哮喘症状或呼吸困难
  • H351 Suspected of causing cancer 怀疑致癌
  • H360 May damage fertility or the unborn child 可能对生育能力或未出生婴儿造成伤害
RTECSVO6250000
Signal word Danger Warning
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Safety Statements
  • S22 Do not breathe dust 不要吸入粉尘;
  • S29/56 Do not empty into drains, dispose of this material and its container at hazardous or special waste collection point 不要排入下水道,在危险废物或特殊废物收集点处置该物料及其容器;
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
Hazard Codes 9
Risk Statements
  • R42/43
Storage condition 储存温度-20°C
UN Number 3077
Packing GroupIII
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 177 mg/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Kidney, Ureter, Bladder - tumors
REFERENCE :
   NTPTR* National Toxicology Program Technical Report Series.  (Research
   Triangle Park, NC 27709) No.206-  Volume(issue)/page/year: NTP-TR-457,1997

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 141 mg/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Liver - tumors
REFERENCE :
   NTPTR* National Toxicology Program Technical Report Series.  (Research
   Triangle Park, NC 27709) No.206-  Volume(issue)/page/year: NTP-TR-457,1997

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 3870 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NIIRDN Drugs in Japan (Ethical Drugs).  (Yakugyo Jiho Co., Ltd., Tokyo,
   Japan)  Volume(issue)/page/year: -,420,1990

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 357 mg/kg
TOXIC EFFECTS :
   Behavioral - hallucinations, distorted perceptions
   Behavioral - headache
REFERENCE :
   JTCTDW Journal of Toxicology, Clinical Toxicology.  (Marcel Dekker, 270
   Madison Ave., New York, NY 10016)  V.19-    1982-  Volume(issue)/page/year:
   29,543,1991

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 3200 mg/kg/31D-I
TOXIC EFFECTS :
   Blood - agranulocytosis
   Blood - other changes
   Skin and Appendages - dermatitis, allergic (after systemic exposure)
REFERENCE :
   JRSMD9 Journal of the Royal Society of Medicine.  (Oxford Univ. Press,
   Walton St., Oxford OX2 6DP, UK)  V.71-    1978-  Volume(issue)/page/year:
   73,587,1980

{hazard_com

TYPE OF TEST            : TDLo - Lowest

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - woman
DOSE/DURATION           : 140 mg/kg/2W-I
TOXIC EFFECTS :
   Behavioral - headache
   Gastrointestinal - hypermotility, diarrhea
   Nutritional and Gross Metabolic - body temperature increase
REFERENCE :
   LANCAO Lancet.  (7 Adam St., London WC2N 6AD, UK)  V.1-    1823-
   Volume(issue)/page/year: 1,917,1984

TYPE OF TEST            : LD50 - Lethal dose, 50 per

TYPE OF TEST            : Micronucleus test
TEST SYSTEM             : Human Lymphocyte
DOSE/DURATION           : 40 mg/L
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 222,27,1989

TYPE OF TEST            : Sister chromatid exchange
TEST SYSTEM             : Human Lymphocyte
DOSE/DURATION           : 20 mg/L
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 222,27,1989

TYPE OF TEST            : Micronucleus test
ROUTE OF EXPOSURE       : Oral
TEST SYSTEM             : Rodent - mouse
DOSE/DURATION           : 5634 mg/kg
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 283,53,1992

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 7 gm/kg
SEX/DURATION            : male 35 day(s) pre-mating
TOXIC EFFECTS :

{

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 43875 mg/kg
SEX/DURATION            : male 13 week(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Paternal Effects - testes, epididymis, sperm duct
REFERENCE :
   NTPTR* National Toxicology Program Technical Report Series.  (Research
   Triangle Park, NC 27709) No.206-  Volume(issue)/page/year: NTP-TR-457,1997

TYPE OF TEST            : TDL

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 16800 mg/kg
SEX/DURATION            : male 28 day(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
   number of implants per female; total number of implants per corpora lutea)
REFERENCE :
   CCPTAY Contraception.  (Geron-X, Inc., POB 1108, Los Altos, CA 94022)  V.1-
   1970-  Volume(issue)/page/year: 37,539,1988

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - woman
DOSE                    : 8100 mg/kg
SEX/DURATION            : female 1-40 week(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - craniofacial
   (including nose and tongue)
   Reproductive - Specific Developmental Abnormalities - cardiovascular
   (circulatory) system
REFERENCE :
   NEJMAG New England Journal of Medicine.  (Massachusetts Medical Soc., 10
   Shattuck St., Boston, MA 02115)  V.198-    1928-  Volume(issue)/page/year:
   318,1128,1988

其他信息

  • Sigma Aldrich:599-79-1(sigmaaldrich)
  • MOL 文件:599-79-1.mol
  • 柳氮磺胺吡啶
  • MSDS 信息:Salicylazosulfapyridine(599-79-1).msds
  • F:8
  • 柳氮磺吡啶价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/04/16 S0580 柳氮磺吡啶 Sulfasalazine 25G 987元
  • Sulfasalazine 是一种磺胺剂,是Mesalazine的衍生物,主要用作抗炎剂。
  • 用途一:肠道磺胺药,与结缔组织有特殊的亲和力,系目前治疗慢性溃疡结膜炎较好的药物
  • 柳氮磺吡啶价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2014/06/02 S0580 柳氮磺吡啶 Sulfasalazine 25G 889元
  • 方法一:2-氨基吡啶与N-乙酰氨基-苯磺酰氯反应,随后水解得到磺酰吡啶胺,即磺胺吡啶,磺胺吡啶重氮化后与水杨酸偶合、酸化即制得柳氮磺胺吡啶。
  • 上游原料:乙酸 --> 2-氨基吡啶 --> 苯磺酰氯 --> N-乙酰苯胺 --> 磺胺吡啶
  • 用途二:肠道磺胺药,与结缔组织有特殊的亲和力,系目前治疗慢性溃疡结膜炎较好的药物。

系列性分类


相关产品推荐